Terms: = Head and neck cancer AND CIC, ENSG00000079432, 23152, Q96RK0, KIAA0306 AND Prognosis
13 results:
1. Mapping Cell-in-Cell Structures in Oral Squamous Cell Carcinoma.
Siquara da Rocha LO; Souza BSF; Coletta RD; Lambert DW; Gurgel Rocha CA
Cells; 2023 Oct; 12(19):. PubMed ID: 37830632
[TBL] [Abstract] [Full Text] [Related]
2. Molecular characterisation of tumours of the lacrimal apparatus.
Vibert R; Cyrta J; Girard E; Vacher S; Dupain C; Antonio S; Wong J; Baulande S; De Sousa JMF; Vincent-Salomon A; Masliah-Planchon J; Girard N; Le Tourneau C; Kamal M; Bièche I
Histopathology; 2023 Dec; 83(6):925-935. PubMed ID: 37706251
[TBL] [Abstract] [Full Text] [Related]
3. Developing a nomogram model and prognostic analysis of nasopharyngeal squamous cell carcinoma patients: a population-based study.
Liu K; Wang J
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12165-12175. PubMed ID: 37428250
[TBL] [Abstract] [Full Text] [Related]
4. p53 functional states are associated with distinct aldehyde dehydrogenase transcriptomic signatures.
Gui S; Xie X; O'Neill WQ; Chatfield-Reed K; Yu JG; Teknos TN; Pan Q
Sci Rep; 2020 Jan; 10(1):1097. PubMed ID: 31974410
[TBL] [Abstract] [Full Text] [Related]
5. [cic-rearranged sarcoma:a clinicopathological analysis of 10 cases].
Zhao L; Sun M; Weng QY; Yu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2019 Jul; 48(7):515-521. PubMed ID: 31288305
[No Abstract] [Full Text] [Related]
6. miR-15b inhibits cancer-initiating cell phenotypes and chemoresistance of cisplatin by targeting TRIM14 in oral tongue squamous cell cancer.
Wang X; Guo H; Yao B; Helms J
Oncol Rep; 2017 May; 37(5):2720-2726. PubMed ID: 28350138
[TBL] [Abstract] [Full Text] [Related]
7. Cell-in-cell structures are more potent predictors of outcome than senescence or apoptosis in head and neck squamous cell carcinomas.
Schenker H; Büttner-Herold M; Fietkau R; Distel LV
Radiat Oncol; 2017 Jan; 12(1):21. PubMed ID: 28100275
[TBL] [Abstract] [Full Text] [Related]
8. High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis.
Michifuri Y; Hirohashi Y; Torigoe T; Miyazaki A; Kobayashi J; Sasaki T; Fujino J; Asanuma H; Tamura Y; Nakamori K; Hasegawa T; Hiratsuka H; Sato N
Pathol Int; 2012 Oct; 62(10):684-9. PubMed ID: 23005595
[TBL] [Abstract] [Full Text] [Related]
9. Serum circulating immune complexes as prognostic indicators in premalignant and malignant lesions of oral cavity during and following radiotherapy.
Rai S; Mody RN
J Cancer Res Ther; 2012 Jan; 8 Suppl 1():S116-22. PubMed ID: 22322729
[TBL] [Abstract] [Full Text] [Related]
10. Squamous cell carcinoma antigen, circulating immune complexes, and immunoglobulins in monitoring squamous cell carcinoma of head and neck: a study of the hellenic co-operative oncology group (HeCOG).
Makrantonakis P; Pectasides D; Aggouridakis C; Visvikis A; Daniilidis J; Fountzilas G
Am J Clin Oncol; 1999 Dec; 22(6):542-9. PubMed ID: 10597736
[TBL] [Abstract] [Full Text] [Related]
11. Evaluation of cell-mediated immunity and circulating immune complexes as prognostic indicators in cancer patients.
Aziz M; Akhtar S; Malik A
Cancer Detect Prev; 1998; 22(2):87-99. PubMed ID: 9544429
[TBL] [Abstract] [Full Text] [Related]
12. Identification of acute-phase proteins (APP) in circulating immune complexes (cic) in esophageal cancer patients' sera.
Croce MV; Segal-Eiras A
Cancer Invest; 1996; 14(5):421-6. PubMed ID: 8816857
[TBL] [Abstract] [Full Text] [Related]
13. CD2 related immunoregulation in oral cancer.
Balaram P; Meenattoor G; Nalinakumari KR; Hareendran NK; Padmanabhan TK; Nair MK
Eur J Cancer B Oral Oncol; 1994 Jan; 30B(1):43-6. PubMed ID: 9135972
[TBL] [Abstract] [Full Text] [Related]
